Martingale Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Buy |
44,121
+14,322
| +48% | +$134K | 0.01% | 645 |
|
|
2025
Q1 | $212K | Buy |
29,799
+8,400
| +39% | +$59.7K | 0.01% | 734 |
|
|
2024
Q4 | $250K | Buy |
+21,399
| New | +$250K | 0.01% | 715 |
|
|
2018
Q2 | – | Sell |
-31,717
| Closed | -$669K | – | 1006 |
|
|
2018
Q1 | $669K | Sell |
31,717
-300
| -0.9% | -$6.33K | 0.01% | 794 |
|
|
2017
Q4 | $616K | Sell |
32,017
-290
| -0.9% | -$5.58K | 0.01% | 790 |
|
|
2017
Q3 | $803K | Buy |
+32,307
| New | +$803K | 0.01% | 776 |
|